Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

HIV Vaccine Development

Series
HIV
Video Audio Embed
Professor Tomas Hanke tells us about his research on HIV vaccine development.
The enormous variations in HIV present big challenges in the development of a vaccine. Professor Tomáš Hanke focuses on the most conserved regions of the HIV-1 proteome, with the aim of developing a vaccine for both adult and mother-to-child transmission. Professor Hanke's group tests novel ideas and vaccine strategies, and focusses on a safe but rapid translation of the most promising laboratory results to phase I/II clinical trials in human volunteers. The ultimate goal is to develop a safe, effective and accessible HIV vaccine.

More in this series

View Series
HIV

How can we live with HIV?

Dr Lucy Dorrell tells us how our immune system controls HIV and how we can live with this virus.
Next
Licence
Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Episode Information

Series
HIV
People
Tomas Hanke
Keywords
clinical trials
T-cell
vaccine
hiv
immune response
Department: Nuffield Department of Clinical Medicine
Date Added: 22/05/2012
Duration: 00:05:48

Subscribe

Apple Podcast Video Apple Podcast Audio Audio RSS Feed Video RSS Feed

Download

Download Video Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford